3 short-term Biotech plays

Livewire Equities


3 short-term Biotech plays. Scott Power attended the Bioshares Biotech summit and has identified 3 stocks that he thinks are set to rise. Power says In my opinion (and assuming the broader market holds together) the following stocks are going to move higher within the short term (one to two months): 1) Impedimed (IPD) - Investor interest is strong and growing as the importance and value of the ugraded reimbursement code approaches for its technology. 2) Innate Immunotherapuetics (IIL) expects its Phase 2b MS trial to start in August. A key milestone. 3) Rhinomed (RNO) recently received FDA approval for its nasal technology as a medical device, putting more substance behind the product. The sleep and snoring product is set for launch in Oct/Nov this year. Read more here: (VIEW LINK)

1 topic

Livewire Equities
Livewire Equities

The Livewire Equities feed brings you a range of insights that relate to Australian equities


No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.


Sign In or Join Free to comment